Cargando…
Global Wnt Inhibition With a Porcupine Inhibitor Decreases Established Trabecular Bone in a Mouse Model of Fibrous Dysplasia
Background: G protein-coupled receptors (GPCRs) mediate a wide spectrum of physiological functions, including bone development and remodeling. Fibrous dysplasia (FD) is a common skeletal dysplasia caused by increased G(s)-GPCR signaling and characterized by fibrotic expansile bone lesions. FD has no...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089136/ http://dx.doi.org/10.1210/jendso/bvab048.475 |
_version_ | 1783686975416434688 |
---|---|
author | Lung, Hsuan Moody, Tania Wentworth, Kelly Kang, Misun Ho, Sunita Hsiao, Edward |
author_facet | Lung, Hsuan Moody, Tania Wentworth, Kelly Kang, Misun Ho, Sunita Hsiao, Edward |
author_sort | Lung, Hsuan |
collection | PubMed |
description | Background: G protein-coupled receptors (GPCRs) mediate a wide spectrum of physiological functions, including bone development and remodeling. Fibrous dysplasia (FD) is a common skeletal dysplasia caused by increased G(s)-GPCR signaling and characterized by fibrotic expansile bone lesions. FD has no effective medical treatments. Our prior studies used the ColI(2.3)(+)/Rs1(+) mouse model where osteoblastic-cell G(s) signaling induced a dramatic FD-like phenotype and increased Wnt signaling, which we hypothesized is a major driver of the phenotype. Furthermore, we previously showed that blocking Rs1 expression could reverse the abnormal bone phenotype, providing proof-of-concept for finding therapies for FD. Methods: Long bone stromal cells from wildtype and ColI(2.3)(+)/Rs1(+) 9-week-old male mice were analyzed by single-cell RNAseq to identify potential cellular sources of Wnt ligands. We compared these findings with global inhibition of Wnt activity by oral administration of the porcupine inhibitor LGK974 to ColI(2.3)(+)/Rs1(+) mice. These mice were analyzed by histology and micro-computed tomography (micro-CT). Results: Control and ColI(2.3)(+)/Rs1(+) bones showed similar scRNAseq results, except for a large expansion of osteoblastic lineage cells and increased differential expression (DE) genes in this cluster. Expression of G(i)-GPCRs was increased, potentially as compensation for the strong G(s)-GPCR pathway activation induced by Rs1 expression. We also found increased GH/IGF1 pathway activation in the osteoblastic cluster, and expression of multiple Wnt ligands within multiple cell clusters. We also identified a cell population unique to the ColI(2.3)(+)/Rs1(+) FD-like bone lesions. Broad Wnt production inhibition of porcupine by LGK974 induced dose-dependent resorption of the abnormal FD bone shown by decreased bone volume and trabecular thickness; however, the fibrocellular infiltrate in the ColI(2.3)(+)/Rs1(+) mice was still present. Conclusions: FD-like bones of ColI(2.3)(+)/Rs1(+) mice showed broad activation of Wnt signaling in multiple cell types, suggesting both cell autonomous and non-cell autonomous activity. Broad Wnt inhibition decreased established FD-like trabecular bone, but the fibrocellular infiltrate did not fully reverse. These results suggest distinct roles of G(s)-GPCR and Wnt signaling in FD pathogenesis. |
format | Online Article Text |
id | pubmed-8089136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-80891362021-05-06 Global Wnt Inhibition With a Porcupine Inhibitor Decreases Established Trabecular Bone in a Mouse Model of Fibrous Dysplasia Lung, Hsuan Moody, Tania Wentworth, Kelly Kang, Misun Ho, Sunita Hsiao, Edward J Endocr Soc Bone and Mineral Metabolism Background: G protein-coupled receptors (GPCRs) mediate a wide spectrum of physiological functions, including bone development and remodeling. Fibrous dysplasia (FD) is a common skeletal dysplasia caused by increased G(s)-GPCR signaling and characterized by fibrotic expansile bone lesions. FD has no effective medical treatments. Our prior studies used the ColI(2.3)(+)/Rs1(+) mouse model where osteoblastic-cell G(s) signaling induced a dramatic FD-like phenotype and increased Wnt signaling, which we hypothesized is a major driver of the phenotype. Furthermore, we previously showed that blocking Rs1 expression could reverse the abnormal bone phenotype, providing proof-of-concept for finding therapies for FD. Methods: Long bone stromal cells from wildtype and ColI(2.3)(+)/Rs1(+) 9-week-old male mice were analyzed by single-cell RNAseq to identify potential cellular sources of Wnt ligands. We compared these findings with global inhibition of Wnt activity by oral administration of the porcupine inhibitor LGK974 to ColI(2.3)(+)/Rs1(+) mice. These mice were analyzed by histology and micro-computed tomography (micro-CT). Results: Control and ColI(2.3)(+)/Rs1(+) bones showed similar scRNAseq results, except for a large expansion of osteoblastic lineage cells and increased differential expression (DE) genes in this cluster. Expression of G(i)-GPCRs was increased, potentially as compensation for the strong G(s)-GPCR pathway activation induced by Rs1 expression. We also found increased GH/IGF1 pathway activation in the osteoblastic cluster, and expression of multiple Wnt ligands within multiple cell clusters. We also identified a cell population unique to the ColI(2.3)(+)/Rs1(+) FD-like bone lesions. Broad Wnt production inhibition of porcupine by LGK974 induced dose-dependent resorption of the abnormal FD bone shown by decreased bone volume and trabecular thickness; however, the fibrocellular infiltrate in the ColI(2.3)(+)/Rs1(+) mice was still present. Conclusions: FD-like bones of ColI(2.3)(+)/Rs1(+) mice showed broad activation of Wnt signaling in multiple cell types, suggesting both cell autonomous and non-cell autonomous activity. Broad Wnt inhibition decreased established FD-like trabecular bone, but the fibrocellular infiltrate did not fully reverse. These results suggest distinct roles of G(s)-GPCR and Wnt signaling in FD pathogenesis. Oxford University Press 2021-05-03 /pmc/articles/PMC8089136/ http://dx.doi.org/10.1210/jendso/bvab048.475 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Bone and Mineral Metabolism Lung, Hsuan Moody, Tania Wentworth, Kelly Kang, Misun Ho, Sunita Hsiao, Edward Global Wnt Inhibition With a Porcupine Inhibitor Decreases Established Trabecular Bone in a Mouse Model of Fibrous Dysplasia |
title | Global Wnt Inhibition With a Porcupine Inhibitor Decreases Established Trabecular Bone in a Mouse Model of Fibrous Dysplasia |
title_full | Global Wnt Inhibition With a Porcupine Inhibitor Decreases Established Trabecular Bone in a Mouse Model of Fibrous Dysplasia |
title_fullStr | Global Wnt Inhibition With a Porcupine Inhibitor Decreases Established Trabecular Bone in a Mouse Model of Fibrous Dysplasia |
title_full_unstemmed | Global Wnt Inhibition With a Porcupine Inhibitor Decreases Established Trabecular Bone in a Mouse Model of Fibrous Dysplasia |
title_short | Global Wnt Inhibition With a Porcupine Inhibitor Decreases Established Trabecular Bone in a Mouse Model of Fibrous Dysplasia |
title_sort | global wnt inhibition with a porcupine inhibitor decreases established trabecular bone in a mouse model of fibrous dysplasia |
topic | Bone and Mineral Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089136/ http://dx.doi.org/10.1210/jendso/bvab048.475 |
work_keys_str_mv | AT lunghsuan globalwntinhibitionwithaporcupineinhibitordecreasesestablishedtrabecularboneinamousemodeloffibrousdysplasia AT moodytania globalwntinhibitionwithaporcupineinhibitordecreasesestablishedtrabecularboneinamousemodeloffibrousdysplasia AT wentworthkelly globalwntinhibitionwithaporcupineinhibitordecreasesestablishedtrabecularboneinamousemodeloffibrousdysplasia AT kangmisun globalwntinhibitionwithaporcupineinhibitordecreasesestablishedtrabecularboneinamousemodeloffibrousdysplasia AT hosunita globalwntinhibitionwithaporcupineinhibitordecreasesestablishedtrabecularboneinamousemodeloffibrousdysplasia AT hsiaoedward globalwntinhibitionwithaporcupineinhibitordecreasesestablishedtrabecularboneinamousemodeloffibrousdysplasia |